Skip to content

Chemi

Recent events

Recent events tied to this brand in public sources.

Back to profile1 entries

  1. 2021

    Zydus and CHEMI sign license and supply agreement for enoxaparin injection

    Zydus Pharmaceuticals Inc. signed a license and supply agreement with CHEMI SpA for the generic equivalent of Lovenox in seven dosage strengths in the United States. CHEMI will manufacture and supply the injection, and Zydus will commercialize it in the US.